Tim Tyson
Direktor/Vorstandsmitglied bei SYROS PHARMACEUTICALS, INC.
Vermögen: 148 871 $ am 31.01.2020
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Steve Hoffman | M | 61 |
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 13 Jahre |
| Michael Demurjian | M | 60 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 9 Jahre |
| Richard Cunningham | M | 54 |
Icagen-T, Inc.
 Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | 4 Jahre |
| Nancy Simonian | M | 63 | 12 Jahre | |
| Donald DeGolyer | M | 63 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 6 Jahre |
| Keith Lyon | M | - |
TriRx Pharmaceutical Services LLC
 TriRx Pharmaceutical Services LLC Medical/Nursing ServicesHealth Services TriRx Pharmaceutical Services LLC operates contract development and manufacturing organization which serving the biopharmaceutical market. The company was founded by Keith Lyon and Timothy C. Tyson and is headquartered in Norwalk, CT. | - |
| Pat LePore | M | 69 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 9 Jahre |
| Gerald H. Sokol | M | 81 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 10 Jahre |
| Conley Chee | M | 54 | 3 Jahre | |
| Richard Young | M | 70 | 13 Jahre | |
| Andrew Oh | M | 53 | 2 Jahre | |
| Karen Hunady | F | - | 2 Jahre | |
| Kristin Stephens | F | 51 | 9 Jahre | |
| Jim Scandura | M | - |
TriRx Pharmaceutical Services LLC
TriRx Pharmaceutical Services LLC Medical/Nursing ServicesHealth Services TriRx Pharmaceutical Services LLC operates contract development and manufacturing organization which serving the biopharmaceutical market. The company was founded by Keith Lyon and Timothy C. Tyson and is headquartered in Norwalk, CT. | - |
| S. Gail Eckhardt | M | 66 | 4 Jahre | |
| Mark Korb | M | 57 |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ.
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
| Gerald Quirk | M | 56 | 2 Jahre | |
| James Ford | M | - | 29 Jahre | |
| Peter Wirth | M | 73 | 7 Jahre | |
| Deborah Dunsire | M | 61 | 3 Jahre | |
| Marsha Fanucci | F | 70 | 9 Jahre | |
| Srini Akkaraju Akkaraju | M | 56 | 7 Jahre | |
| Jason Haas | M | 56 | 3 Jahre | |
| Lisa Roberts | F | - | 12 Jahre | |
| Graham Rivers | M | - | 26 Jahre | |
| Michael Taglich | M | 57 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
| Lori Peterson | F | - |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
| David Roth | M | 61 | 9 Jahre | |
| Nathan H. Zahler | M | - |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 11 Jahre |
| Clive P. Kabatznik | M | 66 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
| David Redfern | M | 57 | 30 Jahre | |
| Douglas S. Krafte | M | 64 |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | - |
| John M. Rothman | M | 75 | 4 Jahre | |
| Douglas Giordano | M | 61 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 13 Jahre |
| Edward Roffman | M | 74 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 13 Jahre |
| Shetaun Deering | F | - |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Tommy Thompson | M | 81 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 5 Jahre |
| Richard Sykes | M | 79 |
Glaxo Wellcome Plc
| 7 Jahre |
| J. Pearson | M | 64 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 2 Jahre |
| Charles A. Heimbold | M | - | 20 Jahre | |
| Peter R. Dolan | M | 68 | 18 Jahre | |
| John E. Celentano | M | 64 | 31 Jahre | |
| Julian Heslop | M | 70 |
Glaxo Wellcome Plc
| 13 Jahre |
| Ben Taylor | M | 46 | 3 Jahre | |
| Albert Medwar | M | - | 11 Jahre | |
| Douglas Michels | M | 66 | 4 Jahre | |
| Charles Bramlage | M | 63 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 9 Jahre |
| James Biehl | M | 60 | 5 Jahre | |
| Kevin Kotler | M | 53 | 4 Jahre | |
| Peter Greenleaf | M | 54 | 4 Jahre | |
| Mark W. Durand | M | 64 | 17 Jahre | |
| Harrison Bains | M | 80 | 16 Jahre | |
| Geoffrey Glass | M | 50 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 4 Jahre |
| Jonathan Eckard | M | 50 | 5 Jahre | |
| William B. Stone | M | 81 | 16 Jahre | |
| Robert Dickey | M | 68 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 2 Jahre |
| Niraj Vasisht | M | 61 | 13 Jahre | |
| William Louv | M | - | 21 Jahre | |
| David P. Carberry | M | 71 | 5 Jahre | |
| Charles Bancroft | M | 65 | 36 Jahre | |
| Rosemary Crane | F | 64 | 20 Jahre | |
| Paul Sturman | M | 63 | - | |
| Mary Coleman | F | - | - | |
| Todd Davis | M | 63 | 4 Jahre | |
| William Watson | M | 73 | 5 Jahre | |
| James D. Darnley | M | - | 1 Jahre | |
| Samuel Sears | M | 80 | 7 Jahre | |
| Lawrence Hamilton | M | 66 | 8 Jahre | |
| Michele Korfin | F | 52 | 2 Jahre | |
| Béatrice J. Cazala | F | 67 | 32 Jahre | |
| Robert Rosewell Chai-Onn | M | 52 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 6 Jahre |
| Mark Alles | M | 64 | 4 Jahre | |
| Phillip Sharp | M | 79 | 10 Jahre | |
| Herm Cukier | M | 57 | 2 Jahre | |
| Robert J. DiVasto | M | 68 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.
Glaxo Wellcome Plc
| 15 Jahre |
| Thomas D'Alonzo | M | 80 | 5 Jahre | |
| Michèle Barzach | M | - | 7 Jahre | |
| Michael H. Baker | M | - |
Jacksonville State University
| 6 Jahre |
| Michael A. Griffith | M | 66 |
Aptuit LLC
 Aptuit LLC Miscellaneous Commercial ServicesCommercial Services Aptuit LLC engages in the development of pharmaceutical and biotechnological products. Its offerings include drug design and discovery, preclinical biosciences, API development and manufacture, solid state chemistry, solid and oral dosage form development and manufacture, integrated drug discovery and drug development, Aptuit INDiGO, and physical and analytical chemistry services. The company was founded in December 2004 and is headquartered in Greenwich, CT. | 4 Jahre |
| Amir Nashat | M | 51 | 8 Jahre | |
| Barry I. Feinberg | M | 68 | 4 Jahre | |
| Akber Pabani | M | 58 | - | |
| Alex Howarth | M | 55 | 10 Jahre | |
| John F. Stewart | M | 67 |
US Military Academy
| 4 Jahre |
| Troy L. Thames | M | - |
US Military Academy
| 4 Jahre |
| Richard DeFatta | M | - |
US Military Academy
| 4 Jahre |
| James New | M | 70 | 12 Jahre | |
| Chuck Moratz | M | - |
US Military Academy
| 4 Jahre |
| Bill Weber | M | - |
US Military Academy
| 4 Jahre |
| Manuel Sosa | M | - |
US Military Academy
| 4 Jahre |
| Mitchell P. Cybulski | M | 77 | 6 Jahre | |
| Peter S. Linsley | M | 72 | 14 Jahre | |
| Patrick Colin | M | - | - | |
| Peter Kiener | M | 72 | 18 Jahre | |
| John Stephen Sullivan | M | - |
US Military Academy
| 4 Jahre |
| Ronald J. Prentki | M | 66 | 5 Jahre | |
| Frederick B. Oleson | M | - | 9 Jahre | |
| Barry Wilson | M | 80 | 13 Jahre | |
| Bruce Wendel | M | 70 | 14 Jahre | |
| Robert Jones | M | - | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 92 | 92,00% |
| Vereinigtes Königreich | 9 | 9,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
